ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Cancer
Non-Small-Cell Lung Carcinoma
Cancer
Breast Cancer
Colorectal Cancer
Uterine Cervical Cancer
Triple Negative Breast Cancer

Endometrial Cancer trials near San Antonio, TX, USA:

Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy. (POD1UM-204)

This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...

Active, not recruiting
Endometrial Cancer
Drug: INCAGN02385
Drug: pemigatinib

Phase 2

Incyte
Incyte

San Antonio, Texas, United States and 66 other locations

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Drug: Carboplatin
Biological: durvalumab

Phase 3

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 202 other locations

DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...

Enrolling
Endometrial Cancer
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 244 other locations

Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...

Active, not recruiting
Endometrial Cancer
Drug: Paclitaxel
Drug: Nab-paclitaxel

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

San Antonio, Texas, United States and 242 other locations

This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...

Enrolling
Endometrial Cancer
Drug: Navtemadlin
Drug: Navtemadlin Placebo

Phase 2, Phase 3

Kartos Therapeutics
Kartos Therapeutics

San Antonio, Texas, United States and 82 other locations

standard medical care for the treatment of recurrent or progressive endometrial cancer (EC) following prior therapy. There is an eq...

Enrolling
Endometrial Cancer
Recurrent or Progressive Endometrial Cancer
Drug: Rina-S
Drug: IC

Phase 3

Genmab
Genmab

San Antonio, Texas, United States and 50 other locations

drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Phase 1

Lilly
Lilly

San Antonio, Texas, United States of America and 73 other locations

(ADC), in adult participants with advanced or metastatic solid tumors known to be expressing PTK7. The study employs a sequential dose escal...

Enrolling
Endometrial Cancer
Ovarian Cancer Metastatic Recurrent
Drug: HWK-007

Phase 1

Whitehawk Therapeutics, Inc.

San Antonio, Texas, United States and 11 other locations

Researchers are looking for new ways to treat people with proficient mismatch repair (pMMR) endometrial cancer (EC) that is advance...

Enrolling
Endometrial Cancer
Drug: Carboplatin
Biological: Pembrolizumab

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

San Antonio, Texas, United States and 229 other locations

The purpose of this study is to characterize the safety and tolerability of ALTA2618 in adults with AKT1 E17K-mutant advanced solid tumors....

Enrolling
Metastatic Cancer
Endometrial Cancer
Drug: ALTA2618

Phase 1

Alterome Therapeutics, Inc.

San Antonio, Texas, United States and 50 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems